Pfizer
Miguel C. is a finance leader with extensive experience in strategic planning, financial management, and analytics. Currently serving as the Head of Finance for Commercial Platforms at Pfizer since June 2023, Miguel drives resource allocation and budget control for significant marketing investments. Previously at The Estée Lauder Companies Inc., roles included Executive Director of Finance & Strategy, where leadership in global dashboard development improved performance visibility, and Executive Director of Corporate Financial Planning and Analysis, achieving 97% forecast accuracy. Earlier career stages at Pfizer involved overseeing finances for diversified businesses and leading financial planning for Latin America. Miguel began with a foundation in auditing at Unilever and Ernst & Young, complemented by an M.B.A. from Universidad Anáhuac and a BS in Accounting from Universidad La Salle.
This person is not in any teams
This person is not in any offices
Pfizer
620 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.